Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Patrick Nylund"'
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
In Mantle Cell Lymphoma (MCL), the role of macrophages within the tumour microenvironment (TME) has recently gained attention due to their impact on prognosis and response to therapy. Despite their low absolute number in MCL tumour tissue, recent fin
Externí odkaz:
https://doaj.org/article/3a7278a0a0e7476d87eafe1a29abce44
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Extensive genome-wide sequencing efforts have unveiled the intricate regulatory potential of long non-protein coding RNAs (lncRNAs) within the domain of haematological malignancies. Notably, lncRNAs have been found to directly modulate chromatin arch
Externí odkaz:
https://doaj.org/article/472fedd422e543d3a4451b395ebb962f
Autor:
Patrick Nylund, Berta Garrido-Zabala, Alba Atienza Párraga, Louella Vasquez, Paul Theodor Pyl, George Mickhael Harinck, Anqi Ma, Jian Jin, Fredrik Öberg, Antonia Kalushkova, Helena Jernberg Wiklund
Publikováno v:
Haematologica, Vol 109, Iss 2 (2023)
Multiple myeloma is a heterogeneous hematological disease that originates from the bone marrow and is characterized by the monoclonal expansion of malignant plasma cells. Despite novel therapies, multiple myeloma remains clinically challenging. A com
Externí odkaz:
https://doaj.org/article/54d146f1cd6c4084ae909eaf599b99d0
Autor:
Patrick Nylund, Alba Atienza Párraga, Jakob Haglöf, Elke De Bruyne, Eline Menu, Berta Garrido-Zabala, Anqi Ma, Jian Jin, Fredrik Öberg, Karin Vanderkerken, Antonia Kalushkova, Helena Jernberg-Wiklund
Publikováno v:
Cell Death and Disease, Vol 12, Iss 2, Pp 1-16 (2021)
Abstract Multiple myeloma (MM) is a heterogeneous haematological disease that remains clinically challenging. Increased activity of the epigenetic silencer EZH2 is a common feature in patients with poor prognosis. Previous findings have demonstrated
Externí odkaz:
https://doaj.org/article/102657295ae543ceae01381242f3b978
Autor:
Antonia Kalushkova, Patrick Nylund, Alba Atienza Párraga, Andreas Lennartsson, Helena Jernberg-Wiklund
Publikováno v:
Epigenomes, Vol 5, Iss 4, p 22 (2021)
Aberrant DNA methylation, dysregulation of chromatin-modifying enzymes, and microRNAs (miRNAs) play a crucial role in haematological malignancies. These epimutations, with an impact on chromatin accessibility and transcriptional output, are often ass
Externí odkaz:
https://doaj.org/article/4876a47cec874f74bedda65c14faac8d
Autor:
Fredrik Öberg, Elke De Bruyne, Antonia Kalushkova, Eline Menu, Jakob Haglöf, Helena Jernberg-Wiklund, Berta Garrido-Zabala, Alba Atienza Párraga, Karin Vanderkerken, Anqi Ma, Patrick Nylund, Jian Jin
Publikováno v:
Cell Death and Disease, Vol 12, Iss 2, Pp 1-16 (2021)
Cell Death & Disease
Cell Death & Disease
Multiple myeloma (MM) is a heterogeneous haematological disease that remains clinically challenging. Increased activity of the epigenetic silencer EZH2 is a common feature in patients with poor prognosis. Previous findings have demonstrated that meta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d83db95730eadda91d9fa2550ab9ed8
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-434805
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-434805